Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-Naive Prostate Cancer”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT00959959
What this trial is testing

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 49
Testing effectiveness (Phase 2)Study completedNCT02903160
What this trial is testing

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04267887
What this trial is testing

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
OHSU Knight Cancer Institute 7
Early research (Phase 1)Active Not RecruitingNCT05917860
What this trial is testing

Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer

Who this might be right for
Localized Prostate CarcinomaCastration-Naive Prostate CancerIntermediate Risk Prostate Cancer+1 more
Turku University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT04992026
What this trial is testing

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Who this might be right for
ProstatectomyOligometastatic Prostate CancerAbiraterone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05658003
What this trial is testing

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 63
Large-scale testing (Phase 3)Active Not RecruitingNCT02257736
What this trial is testing

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Aragon Pharmaceuticals, Inc. 982
Large-scale testing (Phase 3)Study completedNCT01591122
What this trial is testing

Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 313
Testing effectiveness (Phase 2)Study completedNCT01666314
What this trial is testing

Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 137
Large-scale testing (Phase 3)Study completedNCT02043678
What this trial is testing

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

Who this might be right for
Prostatic Neoplasms
Bayer 806
Not applicableStudy completedNCT02471469
What this trial is testing

Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Radboud University Medical Center 40
Not applicableStudy completedNCT05520138
What this trial is testing

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 5,506
Early research (Phase 1)Study completedNCT01784757
What this trial is testing

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 30
Large-scale testing (Phase 3)Study completedNCT01193244
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,560
Testing effectiveness (Phase 2)UnknownNCT01487902
What this trial is testing

The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Asan Medical Center 90
Testing effectiveness (Phase 2)UnknownNCT01296243
What this trial is testing

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Genta Incorporated 57
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT04179864
What this trial is testing

Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Epizyme, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT02692976
What this trial is testing

Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Prostatic NeoplasmsImmunotherapyDendritic Cells+1 more
Radboud University Medical Center 21
Not applicableStudy completedNCT05968599
What this trial is testing

Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 2,731
Load More Results